These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 1709802)

  • 1. Selective antiviral activity of synthetic soluble L-tyrosine and L-dopa melanins against human immunodeficiency virus in vitro.
    Montefiori DC; Zhou JY
    Antiviral Res; 1991 Jan; 15(1):11-25. PubMed ID: 1709802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of human immunodeficiency virus type 1 replication and cytopathicity by synthetic soluble catecholamine melanins in vitro.
    Montefiori DC; Modliszewski A; Shaff DI; Zhou J
    Biochem Biophys Res Commun; 1990 Apr; 168(1):200-5. PubMed ID: 2327999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dextran sulfate blocks antibody binding to the principal neutralizing domain of human immunodeficiency virus type 1 without interfering with gp120-CD4 interactions.
    Callahan LN; Phelan M; Mallinson M; Norcross MA
    J Virol; 1991 Mar; 65(3):1543-50. PubMed ID: 1995952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective inhibitory activity of polyhydroxycarboxylates derived from phenolic compounds against human immunodeficiency virus replication.
    Schols D; Wutzler P; Klöcking R; Helbig B; De Clercq E
    J Acquir Immune Defic Syndr (1988); 1991; 4(7):677-85. PubMed ID: 1675677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of serotonin and melanin on in vitro HIV-1 infection.
    Sidibe S; Saal F; Rhodes-Feuillette A; Lagaye S; Pelicano L; Canivet M; Peries J; Dianoux L
    J Biol Regul Homeost Agents; 1996; 10(1):19-24. PubMed ID: 9049777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of recombinant gp120 and gp160 from HIV-1: binding to monoclonal antibodies and soluble CD4.
    Moore JP; McKeating JA; Jones IM; Stephens PE; Clements G; Thomson S; Weiss RA
    AIDS; 1990 Apr; 4(4):307-15. PubMed ID: 2190605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AIDS pathogenesis: HIV envelope and its interaction with cell proteins.
    Habeshaw JA; Dalgleish AG; Bountiff L; Newell AL; Wilks D; Walker LC; Manca F
    Immunol Today; 1990 Nov; 11(11):418-25. PubMed ID: 2078296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of anti-human immunodeficiency virus action of polyoxometalates, a class of broad-spectrum antiviral agents.
    Yamamoto N; Schols D; De Clercq E; Debyser Z; Pauwels R; Balzarini J; Nakashima H; Baba M; Hosoya M; Snoeck R
    Mol Pharmacol; 1992 Dec; 42(6):1109-17. PubMed ID: 1282664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adhesion mediated by intercellular adhesion molecule 1 attenuates the potency of antibodies that block HIV-1 gp160-dependent syncytium formation.
    Berman PW; Nakamura GR
    AIDS Res Hum Retroviruses; 1994 May; 10(5):585-93. PubMed ID: 7917519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of a leukocyte adhesion receptor (LFA-1) in HIV-induced syncytium formation.
    Hildreth JE; Orentas RJ
    Science; 1989 Jun; 244(4908):1075-8. PubMed ID: 2543075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance to human immunodeficiency virus 1 infection of SCID mice reconstituted with peripheral blood leukocytes from donors vaccinated with vaccinia gp160 and recombinant gp160.
    Mosier DE; Gulizia RJ; MacIsaac PD; Corey L; Greenberg PD
    Proc Natl Acad Sci U S A; 1993 Mar; 90(6):2443-7. PubMed ID: 8460155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interference with human immunodeficiency virus (HIV) replication by CD8+ T cells in peripheral blood leukocytes of asymptomatic HIV carriers in vitro.
    Kannagi M; Masuda T; Hattori T; Kanoh T; Nasu K; Yamamoto N; Harada S
    J Virol; 1990 Jul; 64(7):3399-406. PubMed ID: 1693704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sulfonic acid polymers as a new class of human immunodeficiency virus inhibitors.
    Mohan P; Schols D; Baba M; De Clercq E
    Antiviral Res; 1992 Jun; 18(2):139-50. PubMed ID: 1384428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies against defined carbohydrate structures of Candida albicans protect H9 cells against infection with human immunodeficiency virus-1 in vitro.
    Müller WE; Bachmann M; Weiler BE; Schröder HC; Uhlenbruck G; Shinoda T; Shimizu H; Ushijima H
    J Acquir Immune Defic Syndr (1988); 1991; 4(7):694-703. PubMed ID: 2051308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulatory effect of N-acetyl-L-cysteine on the HIV-1 multiplication in chronically and acutely infected cell lines.
    Pani A; Marongiu ME; La Colla P
    Antiviral Res; 1993 Sep; 22(1):31-43. PubMed ID: 8250542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4+ lymphocyte function with early human immunodeficiency virus infection.
    Gurley RJ; Ikeuchi K; Byrn RA; Anderson K; Groopman JE
    Proc Natl Acad Sci U S A; 1989 Mar; 86(6):1993-7. PubMed ID: 2564677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of HIV-1 infection and preservation of CD4 function by the binding of CPFs to gp120.
    Finberg RW; Diamond DC; Mitchell DB; Rosenstein Y; Soman G; Norman TC; Schreiber SL; Burakoff SJ
    Science; 1990 Jul; 249(4966):287-91. PubMed ID: 2115689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specificity of antipeptide antibodies produced against V2 and V3 regions of the external envelope of human immunodeficiency virus type 2.
    Babas T; Benichou S; Guetard D; Montagnier L; Bahraoui E
    Mol Immunol; 1994 Apr; 31(5):361-9. PubMed ID: 8152439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restoration of cell surface CD4 expression in human immunodeficiency virus type 1-infected cells by treatment with a Tat antagonist.
    Shahabuddin M; Volsky B; Hsu MC; Volsky DJ
    J Virol; 1992 Nov; 66(11):6802-5. PubMed ID: 1404619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of human epidermal Langerhans cells with HIV-1 viral envelope proteins (gp 120 and gp 160s) involves a receptor-mediated endocytosis independent of the CD4 T4A epitope.
    Dezutter-Dambuyant C; Schmitt DA; Dusserre N; Hanau D; Kolbe HV; Kieny MP; Cazenave JP; Schmitt D; Pasquali JL; Olivier R
    J Dermatol; 1991 Jul; 18(7):377-92. PubMed ID: 1724250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.